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Increased blood pressure in the offspring of diabetic mothers. Am J
Physiol Regul Integr Comp Physiol 288: R1129–R1133, 2005. First
published January 20, 2005; doi:10.1152/ajpregu.00366.2004.—Studies
were conducted in rats to determine the effect of maternal diabetes and
the consequent hyperglycemia on cardiovascular function in the off-
spring. Diabetes was induced in pregnant Wistar rats through strep-
tozotocin injection (50 mg/kg). Cardiovascular parameters were mea-
sured in 2-mo-old offspring animals of diabetic (OD, n  12) and
control rats (OC, n  8). Arterial pressure (AP), heart rate (HR),
baroreflex sensitivity, and vascular responsiveness to phenylephrine
(PH) and sodium nitroprusside (SN) were measured. Angiotensin-
converting enzyme (ACE) activity in heart, kidney, and lung was
determined. OD rats exhibited increases in systolic AP (138  8 vs.
119  6 mmHg, OD vs. OC), with no change in HR (342  21 vs.
364 39 beats per minute (bpm), OD vs. OC). The reflex tachycardia
elicited by SN was reduced in OD rats, as indicated by the slope of the
linear regression (2.2  0.4 vs. 3.6  0.8 bpm/mmHg, OD vs.
OC). Vascular responsiveness to PH was increased 63% in OD rats
compared with OC. OD rats showed increases in ACE activity in
heart, kidney, and lung (1.13  0.24, 3.04  0.86, 40.8  8.9 vs.
0.73  0.19, 1.7  0.45, 28.1  6 nmol His-Leu min1 mg pro-
tein1, OD vs. OC). Results suggest that diabetes during pregnancy
affects cardiovascular function in offspring, seen as hypertension, barore-
flex dysfunction, and activation of tissue renin-angiotensin system.
cardiovascular; heart rate; development; angiotensin-converting en-
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EVIDENCE SUGGESTS THAT THE mother’s lifestyle may have long-
lasting effects on offspring. For example, smoking, alcohol
consumption, and presence of disease states such as diabetes
and hypertension during pregnancy all affect fetal development
(8, 27). Alterations in fetal development could contribute to
pathologies in the adult. With regard to diabetes, even when
treated, the maternal disease has profound consequences on the
fetus, seen as changes in brain, pancreas, lung, kidney, and
heart (2, 14, 21, 44).
To study diabetes in the experimental setting, chemical
toxins have been widely used. Streptozotocin (STZ) is a
pancreatic toxin that induces hyperglycemia, hypoinsulinemia,
polyuria, and weight loss in rats (9, 28, 38, 45). When STZ-
induced hyperglycemia is present during pregnancy, there are
changes in fetal development and metabolism, including
growth restriction and abnormal pancreatic function (5, 22,
36). Epidemiological and animal studies have shown that low
birth weight increases the incidence of cardiovascular disease
and diabetes mellitus in adulthood (3). Intrauterine growth
restriction produced by placental insufficiency in pregnant rats
was associated with marked elevation in blood pressure of the
offspring (1). Adult offspring of STZ-diabetic rats also showed
signs of cardiovascular dysfunction, seen as a reduced response
to endothelium-dependent vasodilators and enhanced norepi-
nephrine-induced vasoconstriction (23).
There is evidence for an association between the develop-
ment of diabetes and the activation of the renin-angiotensin
system (RAS). Experimental (18, 30, 39) and clinical studies
(7, 17, 19, 42) have demonstrated that angiotensin-converting
enzyme (ACE) inhibitors and ANG II receptor type 1 (AT1)
antagonists may be used for treatment and may retard the
development of cardiac disease in diabetes mellitus. A large
clinical trial showed that long-term treatment with losartan
lowered the risk of developing diabetes (33). In animal studies,
evidence exists that ACE levels are increased in diabetic
models and that angiotensin-converting enzyme inhibitor
(ACEI) and angiotensin receptor blockers (ARBs) lower blood
pressure and improve kidney function. Using genetically mod-
ified mice, Huang et al. (26) showed that interactions occur
between ACE and the pathological consequences of renal
function and blood pressure. A general role for RAS in diabe-
tes-induced hypertension is supported by the depressor effects
of ACEI and ARB in rats (25, 29). However, less information
is available on the developmental effects of maternal diabetes,
in particular, its relation to the RAS.
Experiments were conducted to explore the mechanisms by
which maternal diabetes in rats affects the cardiovascular
system in the offspring. Using STZ-diabetic rats, we measured
metabolic and cardiovascular parameters and tissue ACE levels
in the male offspring of diabetic mothers.
MATERIALS AND METHODS
Animals and diabetes induction. Male and female Wistar rats were
obtained from a breeding colony at the University of Sa˜o Paulo (Sa˜o
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Paulo, Brazil). The animals had free access to food and water and
were housed in temperature-controlled rooms (22°C) under a 12:12-h
light-dark cycle. The offspring used in the study (n  20) were
produced from diabetic (n  4) or control (n  2) pregnant female
rats. The Experimental Animal Use Committee of the University of
Sa˜o Paulo approved all animal protocols.
Female and male Wistar rats (250–300 g) were mated. On the 7th
day of pregnancy, rats were fasted for 6 hr, and STZ (50 mg/kg, 10
mM citrate buffer, pH 4.5) was injected into the tail vein. Blood was
collected from a tail cut on days 14 and 21 of gestation. Blood glucose
was measured using the ACCU-CHEK system (Roche Diagnostics,
Mannheim, Germany), which is based on bioamperometry. Results
confirmed a hyperglycemia, blood glucose levels between 250 and
400 mg/dl. Pregnant controls were injected with a citrate buffer. After
parturition, blood glucose and body weight were measured in diabetic
offspring (OD; n 12, 3 animals from each diabetic pregnant rat) and
control rats (OC, n  8; 4 animals from each control pregnant rat) on
postnatal days 3, 15, 30, and 60.
Cardiovascular measurements. At60 days of age, male offspring
from diabetic and control mothers were anesthetized (ketamine and
xylazine 80/40 mg/kg ip), and carotid artery and jugular vein catheters
were inserted for direct measurements of arterial pressure (AP) and
drug administration, respectively. All cardiovascular measurement,
including baroreflex testing, were performed in conscious, freely
moving rats (1 day after surgery). The arterial cannula was connected
to a transducer (Narco Bio-Systems Miniature Pressure Transducer
RP 1500, Austin, TX), and pressure signals were recorded for a
20-min period using a microcomputer equipped with an analog-to-
digital converter (CODAS, 2-kHz sampling frequency, Dataq Instru-
ments, Akron, OH). To assess baroreflex control of heart rate (HR)
and vascular responsiveness, phenylephrine (PH; 0.5 to 8.0 g/kg) or
sodium nitroprusside (SN; 5 to 80 g/kg) was injected into the venous
catheter. The drugs were given intravenously as bolus injections (0.1
ml), resulting in pressor responses from 10 to 40 mmHg. Subsequent
injections were given only after HR and AP had returned to basal
levels. The data were analyzed on a beat-to-beat basis to quantify
changes in AP and HR. Baroreflex sensitivity was reported as values
derived from the slope of the linear regression line for each animal,
and the relationship between change in HR and AP was shown. Vascular
responsiveness to constriction and dilation were evaluated by the
maximum change in AP for each dose of PH and SN, respectively.
Measurement of ACE activity. ACE activity was determined in
neonate (3 day) and adult (60 day) rats using the fluorimetric assay
described by Oliveira et al. (37). Heart, kidney, and lung were quickly
harvested, rinsed, blotted and homogenized in 0.4 M sodium borate
buffer (BB), pH 7.2. Supernatants from homogenized tissues (20 l)
were incubated with 490 or 480 l of assay buffer containing 5 mM
Hip-His-Leu in 0.4 M sodium BB and 0.9 M NaCl, pH 8.3 for 15 or
30 min at 37°C. The reaction was stopped by the addition of 1.2 ml of
0.34 M NaOH. The product, His-Leu, was measured fluorimetrically
at 365-nm excitation and 495-nm emission with a fluorescence spec-
trometer (Shimadzu, RF 1501, Japan). -phthaldialdehyde (100 l ,
20 mg/ml) in methanol was added, and after 10 min, the solution was
acidified with 200 l 3 N HCl and centrifuged in at 3,000 rpm for 10
min at room temperature. To correct for the intrinsic fluorescence of
the tissues, time zero blanks were prepared by adding tissue after
NaOH. All samples were assayed in duplicate. The sensitivity of the
assay is less than or equal to 0.02 nmol mg tissue1 min1; the
fluorescence intensity is linear with the concentration of His-Leu
generated from 0.02 to 15 nmol mg1 min1. The results are expressed
as nmol His-Leu min1 mg1 of protein. Protein was measured with
Bradford’s method (4) using bovine serum albumin as the standard.
Statistical analyses. Data are expressed as mean SD. A Student’s
unpaired t-test was used to compare the two groups. ANOVA for
repeated measures was used for multiple times or drug doses followed
by Tukey’s post hoc comparison. Significance level was established at
P  0.05.
RESULTS
STZ treatment on the 7th day of pregnancy, induced hyper-
glycemia at 14 and 21 days of gestation (313  26 and 347 
58 mg/dl) compared with controls (114  9 mg/dl) (Table 1).
Diabetic dams gave birth to fewer pups than the controls (6 
3 vs. 11  2 pups/litter; P  0.05). ANOVA analysis showed
an overall difference in body weight between the groups with
a decrease seen only at 30 days of age (Table 1). Blood glucose
levels were changed in OD rats. There was a reduction of
50% at 3 days and an increase of 23% at 15 days (Table 1).
The blood glucose level was not different between the groups
at 30 and 60 days of age.
Cardiovascular parameters were evaluated in adult offspring
rats (60 days). Systolic and mean arterial pressure (MAP)
were increased in the diabetic group (Table 2) with no change
in HR. The reflex tachycardia elicited by SN was reduced in
diabetic offspring, as indicated by the slope of the linear
regression relating changes in HR to changes in MAP (2.2
0.4 vs.3.6 0.8 bpm/mmHg in OC group). The bradycardia
elicited by phenylephrine remained unchanged (Fig. 1).
Vascular responsiveness was evaluated by the AP responses
to SN and PH (Fig. 2). SN induced similar reductions in AP in
both groups. The pressor response to PH was greater in OD rats
than in controls.
ACE activity was evaluated in heart, lung, and kidney in
neonates (3 days) and adults (60 days) (Table 3). There were
no group changes in neonates, whereas in adult OD rats, there
were increases in all tissues compared with controls. There was
a significant correlation between systolic arterial pressure
(SAP) and lung ACE in adult rats (linear regression slope 
0.65, r  0.86 and r2  0.75). There were also age-related
changes, seen as lower ACE in heart and higher ACE in lungs
in adults compared with neonates.
DISCUSSION
Results show that hyperglycemia during pregnancy pro-
duced long-lasting hypertension in the male offspring associ-
ated with changes in plasma glucose and tissue ACE activity.
These data emphasize that metabolic changes in the mother
may produce severe consequences for the developing fetus,
leading to long-term changes in the adult.
Hyperglycemia is known to be a pathogenic factor in the
long-term complications of diabetes mellitus. Even during fetal
life, high glucose poses a risk. For example, Dabelea et al. (8)
demonstrated a higher prevalence of diabetes in offspring of
women with hyperglycemia during pregnancy. The effect of
glucose per se was evaluated in an animal study in which
Table 1. Body weight and blood glucose of control
and offspring diabetic rat
Days
Body Weight, gm Blood Glucose, mg/dl
OC OD OC OD
3 6.60.6 5.70.09 616 309*
15 22.80.8 16.51.3 565 735*
30 813 655* 8610 8015
60 2319 20817 445 563
Data are reported as means  SD of offspring control (OC, n  8) and
offspring diabetic rats (OD, n  12). *P  0.05 compared with the OC group
to ANOVA for multiple groups, followed by a Tukey post hoc comparison.
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glucose was infused during the last week of pregnancy (16).
The results showed evidence for glucose intolerance and im-
paired insulin secretion in the rat offspring of the dams treated
with glucose. This is consistent with data in the STZ model in
our study and a previous publication (20). Hyperglycemia in
pregnancy resulted in insulin resistance, changes in glucose
metabolism, and vascular dysfunction in the diabetic offspring.
In vitro studies of ventricular myocytes showed that hypergly-
cemic media impaired relaxation (10). Mesangial cell exposure
to high glucose resulted in significant increases in intracellular
renin activity and ANG II generation (47). Thus much evi-
dence supports a role for hyperglycemia in the development of
cardiovascular changes and detrimental complications.
Cardiovascular pathologies in adult life are associated with
low birth weight and nutritional and metabolic status. Barker et
al. (3) reported that men and women with the lowest birth
weight had the highest blood pressure as adults. Protein re-
striction during pregnancy in rats induces fuel consumption
and hypertension in the adult offspring (24). Canavan et al. (5)
demonstrated that diabetic pregnancy was associated with
suppression in fetal growth, related to reduced protein synthe-
sis. Our results showed that the body weight of diabetic
offspring was not reduced at birth or in neonates. However, at
30 days of life, body weight was significantly lower in the
diabetic offspring, suggesting that the diabetic fetal environ-
ment compromised development.
This is the first report to show sustained hypertension in the
offspring of diabetic rats. In adult rats (2 mo age), MAP and
SAP were increased by 12 and 18 mmHg, respectively. Using
a similar protocol, Holemans et al. (23) observed a decrease in
Fig. 1. Baroreflex sensitivity as measured by dose-response of HR to depres-
sor (nitroprusside) and pressor (phenylephrine) stimuli. Graph shows the
regression analyses for the tachycardia and bradycardia responses in the
control offspring (OC, n 8) and the diabetic offspring rat (OD, n 12). Data
are reported as mean  SD. *P  0.05 for slope vs. OC group, using the
Student’s unpaired t-test).
Table 2. Resting heart rate, diastolic, mean, and systolic
arterial pressure of control and offspring diabetic rat
HR, beats/min DAP, mm Hg MAP, mm Hg SAP, mm Hg
OC 34223 9311 1077 1206
OD 37560 1009 1199* 1389*
Data are reported as mean  SD for offspring control (OC, n  8) and
offspring diabetic (OD, n  12). HR, heart rate; DAP, diastolic arterial
pressure; MAP, mean arterial pressure; SAP, systolic arterial pressure. *P 
0.05 vs. OC, using Student’s unpaired t-test.
Fig. 2. Vascular responsiveness to sodium nitroprusside (A) and phenylephrine
(B) in offspring control (OC, ■, n 8) and offspring diabetic rats (OD, , n 12).
Data are reported as mean  SD. *P  0.05 compared with the OC group to
ANOVA for multiple groups, followed by a Tukey post hoc comparison.
Table 3. Angiotensin-converting enzyme activity of kidney,
lung, and heart of neonatal and adults
control and offspring diabetic rats
ACE activity, nmol His-Leumin1mg1 cell protein
Kidney Lung Heart
Neonatal OC 2.360.34 11.531.0 1.560.4
OD 2.760.48 12.196.8 2.110.75
Adult OC 1.770.45 28.106† 0.730.2†
OD 3.040.86* 40.88.9*† 1.130.24*†
Data are reported as means  SD to offspring control (OC, n  6) and
offspring diabetic rats (OD, n  6). ACE, angiotensin-converting enzyme.
*P  0.05 compared with OC group and †P  0.05 compared with the
neonatal group to ANOVA for multiple groups, followed by a Tukey post hoc
comparison.
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heart rate, but no change in blood pressure in female STZ-
diabetic rat offspring. However, this study was complicated by
the method used for cardiovascular recording. The measure-
ments were made in conscious rats, but on the same day as the
surgical procedures. Furthermore, blood pressure levels were
high in both controls and diabetic offspring, with a SAP of
more than 170 mmHg. This is compared with control levels of
120 mmHg in our study, consistent with normal, nonstress
levels. Studies in humans also suggest a relationship between
maternal diabetes and hypertension in the offspring (6, 41),
similar to what is observed in our study.
It is also important to note that the offspring of diabetic rats
showed changes in baroreflex sensitivity and vascular respon-
siveness to vasoactive drugs. Indeed, baroreflex dysfunction
has been observed in some complex diseases such as hyper-
tension and diabetes. Mancia et al. (35) observed depressed
function in baroreceptors from hypertensive humans. Maeda et
al. (34) demonstrated impairment of tachycardic and brady-
cardic response in STZ-diabetic rats. The present study dem-
onstrated a reduced reflex tachycardic response in offspring of
diabetic rats. This impairment of baroreceptor function may
contribute to the hypertensive state in adult animals. Consid-
ering that hypertension is usually associated with sympathetic
overactivity, the reduced reflex tachycardia may be due to a
lower sympathetic reserve. The vagal withdrawal seems to be
normal because there were no changes in the bradycardia
response induced by increasing arterial pressure. These
changes in the baroreflex function may also be occurring at
other sites of the reflex arc, as in the baroreceptor endings or
the central nervous system (9). In fact, the demonstration of
increasing insulin binding in the nucleus of the tractus soli-
tarius observed in the adult rats from hyperglycemic mothers,
indicates that central control of cardiovascular centers could be
involved in the baroreflex impairment in the present study (32).
In addition, PH produced a greater maximal vasoconstrictor
response, while the vasodilator response to SN was not differ-
ent. Data from in vitro studies using mesenteric arteries from
offspring from diabetic dams also showed an enhanced con-
striction in response to norepinephrine (23). The lack of change
in vasodilatation is consistent with the study of Holemans et al.
(23). However, in this study, the offspring of diabetic rats had
a reduction in relaxation after ACh and bradykinin stimulation,
suggesting impaired synthesis of endothelium-derived vasodi-
lators, like prostacyclin and nitric oxide synthesis. Similar
changes were observed in arteries of STZ-diabetic rats, in
which enhanced vascular sensitivity to norepinephrine and an
impairment in ACh-induced vasodilatation were demonstrated
(43). Furthermore, saturated fat fed during the pregnancy in
diabetic rats induces impairment in endothelium-dependent
dilation and enhanced constrictor responses to norepinephrine
in femoral arteries in 15-day-old diabetic offspring (31). All
these data suggest that in utero events related to the maternal
condition may induce vascular disease in later life. The
progress of cardiovascular disease may be correlated with
smooth muscle and endothelium dysfunction through meta-
bolic (insulin resistance, hyperglycemia, and hypercholesterol-
emia), hormones (renin angiotensin, catecholamine), and neu-
ral changes (sympathetic and parasympathetic) (15). Conse-
quently, vascular sensitivity enhanced by vasoconstrictor
agents may be contributing to the increase in blood pressure in
offspring of diabetic rats.
Tissue ACE activity was measured to provide information
on the relationship between diabetes and the RAS. All com-
ponents of RAS have been identified in the heart, kidney, liver,
and lung (12, 13). Results showed that ACE activity was
enhanced in the heart, kidney, and lung of the offspring of
diabetic rats. There were also global, age-related decreases in
ACE, consistent with results in humans and other animal
species (11). Although circulating ACE is critical in the for-
mation of ANG II and blood pressure regulation, there is less
information on the tissue ACE systems. Some evidence
showed the positive relationship between the development of
hypertension and activity of local ACE in tissues. For example,
Sharifi et al. (40) demonstrated increased ACE activity in
kidney, heart, lung and aorta during the development of two-
kidney, one-clip hypertension in rats, suggesting an important
role of local ACE in the development of hypertension. Fur-
thermore, STZ-diabetic rats showed enhanced blood pressure
accompanied by increases in serum ACE activity (46). Huang
et al. observed that diabetes produced an increase in blood
pressure, specifically, in mice with genetically enhanced ACE
activity (26). Our results have also demonstrated a positive
correlation between systolic arterial pressure and lung ACE.
Because the lung is an important site for angiotensin metabo-
lism, the alterations in ACE may be involved in the blood
pressure changes. It would be important in future studies to
measure circulating ACE activity.
In summary, our study suggests that hyperglycemia in preg-
nancy has long-lasting effects on fetal physiological program-
ming, inducing cardiovascular diseases like hypertension,
baroreflex dysfunction, and activation of RAS in adult life.
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